OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 5.9 EUR -1.01% Market Closed
Market Cap: 129.4m EUR

Intrinsic Value

OSE's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one OSE stock under the Base Case scenario is 12.99 EUR. Compared to the current market price of 5.9 EUR, OSE Immunotherapeutics SA is Undervalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OSE Intrinsic Value
12.99 EUR
Undervaluation 55%
Intrinsic Value
Price
Base Case Scenario

Valuation History
OSE Immunotherapeutics SA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
OSE
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for OSE cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

OSE Immunotherapeutics SA
PAR:OSE
FR
Biotechnology
Market Cap
128.8m EUR
IPO
Mar 30, 2015
FR
Biotechnology
Market Cap
128.8m EUR
IPO
Mar 30, 2015
Price
€false
EPS
€false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OSE?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about OSE Immunotherapeutics SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
OSE Immunotherapeutics SA

Current Assets 69.9m
Cash & Short-Term Investments 16.7m
Receivables 4.1m
Other Current Assets 49m
Non-Current Assets 54m
Long-Term Investments 6.4m
PP&E 3.4m
Intangibles 44m
Other Non-Current Assets 192k
Efficiency

Free Cash Flow Analysis
OSE Immunotherapeutics SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
OSE Immunotherapeutics SA

Revenue
83.4m EUR
Operating Expenses
-39.7m EUR
Operating Income
43.7m EUR
Other Expenses
-6.3m EUR
Net Income
37.4m EUR
Fundamental Scores

OSE Profitability Score
Profitability Due Diligence

OSE Immunotherapeutics SA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional ROE
Exceptional ROIC
Exceptional 1-Year Revenue Growth
47/100
Profitability
Score

OSE Immunotherapeutics SA's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

OSE Solvency Score
Solvency Due Diligence

OSE Immunotherapeutics SA's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
High Altman Z-Score
Low D/E
Long-Term Solvency
64/100
Solvency
Score

OSE Immunotherapeutics SA's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 16.83 EUR with a low forecast of 12.63 EUR and a high forecast of 22.37 EUR.

Lowest
Price Target
12.63 EUR
114% Upside
Average
Price Target
16.83 EUR
185% Upside
Highest
Price Target
22.37 EUR
279% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

OSE Immunotherapeutics SA
does not pay dividends
Shareholder Yield

Current shareholder yield for OSE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

OSE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one OSE stock?

The intrinsic value of one OSE stock under the Base Case scenario is 12.99 EUR.

Is OSE stock undervalued or overvalued?

Compared to the current market price of 5.9 EUR, OSE Immunotherapeutics SA is Undervalued by 55%.

Back to Top